Novo Nordisk Gains as Strategic Exit From Metsera Deal Restores Investor Trust

Market Analysis by covering: Eli Lilly and Company, Pfizer Inc, Novo Nordisk A/S, OMX Copenhagen 25. Read 's Market Analysis on Investing.com

Read Full Article →